This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Byung Chang Kim and a Patent-Based Approach to Colorectal Cancer Diagnosis.
Introduction
Byung Chang Kim is an inventor associated with Seongnam, South Korea, and the National Cancer Center. His patent work addresses a potential method for supporting colorectal cancer diagnosis through analysis of low-mass ions.
Latest Patents
Kim is associated with 1 patent: “Method for Crystallizing Low Mass Ions for Diagnosing Colorectal Cancer and Method for Diagnosing Colorectal Cancer Using Same.” The invention describes using a MALDI-TOF mass spectrometer and biostatistical analysis to identify low-mass ions extracted from a biological sample. It also outlines using those ions to provide information for colorectal cancer diagnosis. The proposed approach aims to offer low-cost, rapid analysis across large areas while enabling reliable discrimination.
Career Highlights
Kim’s listed patent connects his work with diagnostic technology and cancer research. His association with the National Cancer Center places this invention in the context of an institution focused on cancer-related research and care.
Collaborations
Sun Young Kim and Byong Chul Yoo are identified as Kim’s coworkers. The available information does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Byung Chang Kim’s patent describes a mass-spectrometry-based approach to colorectal cancer diagnosis, with an emphasis on speed, cost, and diagnostic discrimination.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile